OOIR: Observatory of International Research

Papers

(The median citation count of Presse Medicale is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Contents	88
Editorial board	65
Contents	46
Long-COVID: Cognitive deficits (brain fog) and brain lesions in non–hospitalized patients	43
Immune checkpoint inhibitor-induced joint involvement	42
Pancreatic islet organoids and organoids on-chip for type 1 diabetes	42
International variability in the diagnosis and management of disorders of consciousness	38
History of measles	35
Kidney disease in multiple myeloma	34
Evolving strategies in the management of transplant-eligible patients with newly diagnosed multiple myeloma	33
Future directions: generative AI, foundation models, and what lies ahead	33
Editorial board	31
Editorial board	30
Adverse effects of immune checkpoint inhibitors in the endocrine system	28
Towards etiological treatments in cardiomyopathies	26
Updates on mechanisms of disease progression in precursor myeloma: Monoclonal gammopathy of undermined significance and smoldering myeloma	25
Pulmonary hypertension in sickle cell disease	24
Editorial board	22
Molecular Imaging in neuroendocrine neoplasias	22
Presentation of polymyalgia rheumatica and large joint polyarthritis in the spectrum of hyper-IgG4-related disease: A case report and literature review	17
Cholera in Haiti	16
The current and future contribution of neuroimaging to the understanding of disorders of consciousness	15
The deep and the deeper: Spinal cord and deep brain stimulation for neuropathic pain	15
Prognosis of consciousness disorders in the intensive care unit	15
Editorial board	14

Heart failure with preserved ejection fraction: New challenges and new hopes	13
Effects of thyroid disruption on neural cells stem fate in the mouse brain	13
Update on the pathogenetic hallmarks of chronic obstructive pulmonary disease	12
Editorial board	11
Cystic fibrosis	11
Renal hemodynamic changes in patients with type 2 diabetes and their clinical impact	11
Gastrointestinal complications of immune checkpoint Inhibitor therapy	11
Letter on the article “Long-COVID: Cognitive deficits (brain fog) and brain lesions in non hospitalized patients”	10
Advice taking in medical decision making	10
Contents	10
Heart failure: A major public health problem	10
Cardiac functional imaging	10
Contents	9
Adrenal functional imaging	9
The Spanish flu	9
A tribute to Guy Meyer	8
COVID-19 and kidney transplantation	8
Imaging in multiple myeloma	8
Risk stratification of acute pulmonary embolism	8
Neurological immune-related adverse events of immune-checkpoint inhibitors: an updated review	7
Elderly patients with venous thromboembolism: Insights from the RIETE registry	7
Sickle cell disease and pregnancy	7
Integrating AI into hospital workflows: implementation strategies and real-world barriers	7
Editorial board	6
Contents	6
Contents	6
Pituitary adenoma & nuclear medicine: Recent outcomes and ongoing developments	6
Contents	5
Preventative and curative treatment of venous thromboembolic disease in cancer patients	5
Bronchiectasis	5
Contents	5
Pre-COPD: Impact on prevention, detection, and treatment	5
Health technology assessment in France	5
Vascular pathophysiology of sickle cell disease	5
Idiopathic pulmonary fibrosis	5
The liver in sickle cell disease	5
Diagnostic management of acute pulmonary embolism	4
Artificial Intelligence in medicine – Between promise and practice	4
Functional imaging in thyroid cancer patients with metastases and therapeutic implications	4
HIV / AIDS as a model for emerging infectious disease: Origin, dating and circumstances of an emblematic epidemiological success	3
Life and death of smallpox	3
Primary ciliary dyskinesia	3
Clinical trials with reno-vascular end points in patients with diabetes: Changing the scenario over the past 20 years	3
Treatment of elderly and frail myeloma patients	3
Vascular malformations	3
The French way of HTA: Between scientific rigor, independence and transparency	3
Advancing the management of acute intermediate-high-risk pulmonary embolism: The enduring legacy of Professor Guy Meyer	3
Lower-limb peripheral arterial disease and amputations in people with diabetes: Risk factors, prognostic value and management	3
What's new in transplantation?	3
Duration of anticoagulation of venous thromboembolism	3

Capillary malformations updates on aetiopathogenesis, diagnosis, and management	3
Adrenocortical organoids: A promising tool for modelling human physiology and translational research	3
Albinism worldwide – genetics, beliefs, and the imperative of global advocacy	3
Integrated care in COPD	2
Editorial	2
Editorial	2
Yellow fever: A brief history of a tropical Virosis	2
Neuropathic pain: Evidence based recommendations	2
Electrical therapies in heart failure: Evolving technologies and indications	2
Clinical pharmacology of antidiabetic drugs: What can be expected of their use?	2
Molecular imaging or functional: An increasingly applied method in all fields of medicine	2
Patient-reported outcome measures: A key to patient-tailored and outcome-driven care in pulmonary embolism survivors	2
Editorial	2
Pulmonary toxicity of immune-checkpoint inhibitors	2
The European reference network on rare lung diseases (ERN-LUNG) ambition to offer better lung health for all	2
Bispecific antibody and chimeric antigen receptor (CAR) modified T-cell in the treatment of multiple myeloma: Where do we stand today?	2
Contents	2
Update on dermatological toxicities of immune checkpoint inhibitors	2
End-stage heart failure: The future of heart transplant and artificial heart	1
Severity of kidney involvement as predictor of death, severe heart failure and renal events in patients with type 2 diabetes: Data from a prospective cohort	1
Editorial	1
Fecal microbiota transplantation: History, procedure and regulatory considerations	1
Chronic heart failure with reduced EF: A decade of major pharmacological innovations	1
Gene-addition/editing therapy in sickle cell disease	1
Diagnostic criteria and etiopathogenesis of type 2 diabetes and its complications: Lessons from the Pima Indians	1
The ongoing challenge of RBC alloimmunization in the management of patients with sickle cell disease	1
Lymphangioleiomyomatosis	1
Immunotherapy and the heart: Understanding the cardiovascular risks of immune checkpoint inhibitors	1
Functional imaging for hyperparathyroidism	1
Editorial board	1
Contents	1
Renal disease in patients with type 2 diabetes: Magnitude of the problem, risk factors and preventive strategies	1
Covid-19, an unfinished story	1
French reimbursement of health technologies: assessment is at the heart of the procedure	1
Features of an adrenal cortical carcinoma on CT scan: A case report	1
Sicca induced by immune checkpoint inhibitors	1
Taking ethics into account: the HAS perspective	1
Health technology assessment in Europe: A comparison of organizations and introduction to the European regulation	1
Optimising recovery of consciousness after coma. From bench to bedside and vice versa	1
Lymphatic malformations revisited: Genetics, clinics and future directions	1